HyClone™ CDM4MAb is a chemically defined and animal-derived component-free (ADCF) medium. This regulatory-friendly medium is developed to increase process yields for the manufacture of antibodies and antibody fragments for therapeutic use in a variety of engineered hybridoma and myeloma cell lines.
Animal-derived component-free.
Chemically defined formulation
Designed for high cell yield and monoclonal antibody (MAb) production.
Allows for direct or sequential adaptation
Manufactured from traceable components according to cGMP guidelines
CDM4MAb medium has been successfully tested in a variety of culture systems, including T-flasks, shaker flasks, and bioreactors including fed-batch and perfusion cultures.
